Sign in Subscribe
Cancer

Radiation-Induced Bystander Effects on Cancer Cell Migration: New Insights

Strategic Insights

— 1 min read

Researchers at Hokkaido University in Sapporo, Japan, have made a crucial discovery regarding the effects of radiation therapy on cancer cell migration. According to their study, published in the International Journal of Molecular Sciences, radiation-induced bystander effects can inadvertently enhance tumor cell motility outside the target volume. This finding has significant implications for therapeutic outcomes.

Key Takeaways:

  • The researchers used HeLa-FUCCI cells, a cervical cancer-derived HeLa cell line integrated with the Fluorescent Ubiquitination-Based Cell Cycle Indicator (FUCCI) probe, to investigate the radiation-induced impacts on cell migration.
  • The study found that without cisplatin treatment, the migration velocity and total distance traveled of out-of-field cells were significantly reduced compared to controls, suggesting a suppressive bystander signal.
  • However, with cisplatin treatment, these parameters significantly increased in both in-field and out-of-field cells, indicating a potential enhancement of tumor cell motility.
  • The research suggests that chemoradiotherapy may inadvertently enhance tumor cell motility outside the target volume, which could have significant implications for therapeutic outcomes.
  • The study utilized deep learning-based imaging analysis to reveal the radiation-induced bystander effects on cancer cell migration and the modulation by cisplatin.

Statistics:

  • The study used 2 Gy X-rays to irradiate the cells, with or without cisplatin treatment.
  • Time-lapse imaging was performed at 15-minute intervals for 24 hours to analyze cell migration.
  • Cell segmentation and tracking algorithms, Cellpose 2.0 and TrackMate 7, were used to analyze the acquired data.
  • The study found that without cisplatin, the migration velocity and total distance traveled of out-of-field cells were significantly reduced (by 23% and 25%, respectively).
  • However, with cisplatin, these parameters significantly increased in both in-field and out-of-field cells by 15% and 18%, respectively.

Sources:

  • International Journal of Molecular Sciences, 2025;26(16).

Read more